Skip to main content
An official website of the United States government

Cancer Prevention Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Sort descending Program Official
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics PAR-25-070 (R21 Clinical Trial Not Allowed) R21 Clinical Trial Not Allowed 01/08/2027 Edward Sauter, M.D., Ph.D.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics PAR-25-069 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/08/2027 Edward Sauter, M.D., Ph.D.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis PAR-25-081 (R01 Clinical Trial Required) R01 Clinical Trial Required 01/08/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Grant Program PAR-25-167 (R01 Clinical Trial Required) R01 Clinical Trial Required 01/08/2027
Notice of Special Interest (NOSI): Advancing Diet and Physical Activity Biomarkers for Assessing Lifestyle Interventions in Cancer Prevention and Cancer Interception Research NOT-CA-24-074 01/08/2027 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research PAR-24-153 (K12 Clinical Trial Optional) K12 Clinical Trial Optional 02/19/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Enhancing Mechanistic Research on Precision Probiotic Therapies PAR-25-211 (R61/R33 Clinical Trial Optional) R61, R33 Clinical Trial Optional 06/03/2027 Gabriela Riscuta, M.D., CNS
Notice of Correction to PAR-25-104, Cancer Prevention and Control Clinical Trials Planning Grant Program NOT-CA-25-023 (R34 Clinical Trials Optional) R34 10/26/2027 Goli Samimi, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-25-103 (U34 Clinical Trials Optional) U34 10/26/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-25-104 (R34 Clinical Trials Optional) R34 10/26/2027 Goli Samimi, Ph.D., M.P.H.